At a glance
ClinicalIndex Comparison RecordN/ACompleted· 19 enrolled
Drug / intervention
Encore Reverse Shoulder Prosthesisdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post Market Study on the Efficacy of the Encore Reverse Shoulder Prosthesis in a Small Group of Subjects
In Brief
An observational study evaluating Encore Reverse Shoulder Prosthesis for Rotator Cuff Deficiency and Glenohumeral Arthritis. Completed, enrolled 19 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the survivorship and efficacy of the Encore Reverse Shoulder Prosthesis in a group of no more than 50 subjects for whom data collection has already begun.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRotator Cuff Deficiency, Glenohumeral Arthritis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2008
First PostedOct 2008
Primary CompletionMay 2009
TodayJul 2026
First PostedOct 2, 2008
Enrollment StartAug 1, 2008
Primary CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 17.8 years ago
Interventions
Encore Reverse Shoulder Prosthesisdevice
rotator cuff deficiency and glenohumeral arthritis